You are viewing: North America Nuclear Medicine Equipment Market analysis

The North America Nuclear Medicine Equipment Market was valued at $2865.9 Million in 2025 and projected to reach to $3555.6 Million by 2030, representing a compound annual growth rate of 4.4%. North America's nuclear medicine equipment market is poised for sustained growth through 2030, driven by an aging population, increasing prevalence of cancer and cardiovascular diseases, and continuous technological advancements in imaging systems.

North America Nuclear Medicine Equipment Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Nuclear Medicine Equipment Market Trends and Insights

  • North America maintains a significant share of the global nuclear medicine equipment market, driven by advanced healthcare infrastructure, high adoption of diagnostic imaging technologies, and substantial investment in medical research facilities.
  • The region's established regulatory framework and reimbursement policies continue to support steady market expansion through 2030. In North America, the nuclear medicine equipment sector benefits from aging demographics, increased prevalence of chronic diseases, and growing demand for non-invasive diagnostic procedures.
  • North America's healthcare providers are increasingly integrating hybrid imaging systems and advanced gamma cameras into clinical workflows, enhancing diagnostic accuracy and patient outcomes.
  • The market growth in North America reflects both technological innovation and rising healthcare expenditure across the United States and Canada..

Key Market Statistics

  • CAGR (2025-2030) 4.4% CAGR
  • Market Size, 2025 ~USD 2865.9 Million
  • Forecast, 2030 ~USD 3555.6 Million
  • Geography North America

North America Nuclear Medicine Equipment Market Overview

Market Leadership Position :

North America commands a dominant share of the global nuclear medicine equipment market, valued at $2,865.9 million in 2025, reflecting the region's advanced healthcare infrastructure and early adoption of cutting-edge diagnostic imaging technologies.

Steady Growth Trajectory :

The North American market is projected to expand from $2,865.9 million in 2025 to $3,555.6 million by 2030, representing a compound annual growth rate of 4.4%, outpacing many other developed regions.

US Market Dominance :

The United States represents the largest segment within North America at $3,311.5 million, driven by extensive healthcare spending, high prevalence of chronic diseases, and widespread adoption of nuclear medicine diagnostics.

Regulatory Support & Innovation :

North America benefits from robust regulatory frameworks, substantial R&D investments, and strong reimbursement policies that accelerate the adoption of advanced nuclear medicine equipment across hospitals and diagnostic centers.

North America Nuclear Medicine Equipment Market Dynamics

  • The region's well-established healthcare infrastructure and favorable reimbursement landscape support widespread adoption of PET/CT, SPECT, and hybrid imaging systems.
  • Investment in nuclear medicine facilities and training programs further strengthens market expansion.
  • The US market will continue to lead regional growth, while Canada contributes steady demand from its advanced healthcare system.
  • Emerging trends include the integration of artificial intelligence in image analysis and the development of more efficient radiopharmaceuticals, positioning North America as a hub for nuclear medicine innovation and clinical excellence..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • North America's nuclear medicine equipment market is valued at $2,865.9 million in 2025 with projected growth to $3,555.6 million by 2030.
    • North America demonstrates a 4.4% CAGR, reflecting steady adoption of advanced diagnostic imaging technologies across the region.
    • North America's mature healthcare infrastructure and strong reimbursement policies support consistent market expansion through 2030.
    • North America's aging population and rising chronic disease prevalence drive demand for non-invasive nuclear medicine diagnostic procedures.

    Nuclear Medicine Equipment Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment DIAGNOSTIC IMAGING CENTERS (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 4.62% from 2025 to 2030
    Largest Segment IMAGING MODALITIES (System Type)
    Market Size Base Year (Billions) ~USD 6.63 (2025)
    Revenue Forecast (Billions) ~USD 8.31 (2030)
    Segments Covered System Type, Type, Therapeutic Area, Dimension, End User, Type 2023–2030

    North America Nuclear Medicine Equipment Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By System Type

    • Imaging Modalities
    • Non- Imaging Modalities
    • Non-Imaging Modalities

    By Type

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gamma/Scintillation Cameras
    • Gm Counters
    • Hybrid Pet
    • Hybrid Spect
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect
    • Standalone Pet
    • Standalone Spect

    By Therapeutic Area

    • Cardiology
    • Neurology
    • Oncology
    • Orthopedics
    • Other Therapeutic Areas
    • Thyroid

    By Dimension

    • 2D
    • 3D

    By End User

    • Cancer Treatment Centers
    • Diagnostic Imaging Centers
    • Hospitals
    • Other End Users

    By Type 2023–2030

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gm Counters
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect

    Target Audience

    • Medical Device Manufacturers : Manufacturers of nuclear medicine equipment need North America-specific market data to optimize product development, pricing strategies, and market entry approaches in the world's largest diagnostic imaging market.
    • Healthcare Facility Operators : Hospital administrators and diagnostic center operators require regional market insights to justify capital investments in nuclear medicine equipment, plan facility upgrades, and assess competitive positioning.
    • Investment & Private Equity Firms : Investors evaluating healthcare technology opportunities need detailed North American market forecasts and growth drivers to assess investment returns and identify acquisition targets in the nuclear medicine sector.
    • Healthcare Consultants & Analysts : Consulting firms and market analysts require comprehensive North America data to support client advisory services, competitive benchmarking, and strategic planning in medical imaging and diagnostics.
    • Regulatory & Policy Bodies : Healthcare regulators and policy makers need market intelligence on North America's nuclear medicine equipment adoption trends to inform reimbursement policies, safety standards, and healthcare infrastructure planning.

    Key Companies in the North America Nuclear Medicine Equipment Market

    CompanyHQOwnershipStrongest segments
    PHILIPSNetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma),Software (Image Management, PACS, Treatment, Analytics, Workflow),Detectors & Counters (GM Counter, Dose Calibrator and Related),
    DIGIRAD CORPORATIONUnited StatesPrivate CompanyImaging – SPECT / Gamma cameras,Imaging – PET,Radiation detection (GM counters, dose calibrators),
    TOSHIBA CORPORATIONJapanPrivate CompanyImaging Equipment (PET, SPECT, Gamma),Radiation Measurement (GM Counter, Dose Calibrator),Software (Image Management, PACS, Treatment, Analytic, Workflow),
    SIEMENS AGGermanyPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Treatment, Analytics, Workflow),Therapy-adjacent Solutions (Onco, Cardio, Neuro, Ortho Planning/Support),
    GE HEALTHCAREUnited StatesPublic CompanyImaging – PET,Imaging – SPECT,Imaging – Gamma cameras,
    SIEMENS HEALTHINEERS AGGermany
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Analytics, Workflow, Treatment Planning Interfaces),Therapy-related Applications (Oncology, Cardiology, Neurology, Orthopedic Planning),
    MIRION TECHNOLOGIES, INC.United StatesPublic CompanyImaging-related equipment (PET/SPECT/Gamma-adjacent QA, detectors, cameras),Radiation measurement & counters (GM counters, dose calibrators, health-physics),Software (image/spectroscopy analysis, QA, workflow, treatment support),
    DOSISOFT SAFrancePrivate CompanyImaging-related software (PET/SPECT/Gamma image management & PACS integration),Treatment planning & dosimetry software (Onco/Cardio/Neuro/Ortho),Analytics & workflow orchestration,
    SEGAMI CORPORATIONJapanPrivate CompanyImaging Equipment (PET/SPECT/Gamma),GM Counters & Dose Calibrators,Nuclear Medicine Software (Image Management, PACS, Treatment, Analytic, Workflow),
    LABLOGIC SYSTEMS LTD.United KingdomPrivate CompanyImaging-adjacent QC hardware (gamma counters, dose calibrator-related QC, radiochromatography hardware),CDS / Image & data management software for radiopharmaceutical workflows,LIMS / workflow and analytic software for nuclear medicine and radiochemistry labs,

    PHILIPS

    Philips is a Dutch multinational public company founded in 1891 with 63,670 employees. The company operates across healthcare, consumer lifestyle, and lighting sectors.

    DIGIRAD CORPORATION

    Digirad Corporation is a United States-based private company founded in 1985 with 194 employees.

    TOSHIBA CORPORATION

    Toshiba Corporation is a Japanese private company founded in 1875 with 106,648 employees, operating across multiple industrial and technology sectors.

    SIEMENS AG

    Siemens AG is a German public company founded in 1847 with 310,312 employees, operating across industrial, infrastructure, and healthcare sectors.

    GE HEALTHCARE

    GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees.

    SIEMENS HEALTHINEERS AG

    Siemens Healthineers AG is a German healthcare company within the Siemens group.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 63,670 employees, operating across healthcare, consumer lifestyle, and lighting sectors.

    MIRION TECHNOLOGIES, INC.

    Mirion Technologies, Inc. is a United States-based public company founded in 2005 with 3,281 employees.

    DOSISOFT SA

    Dosisoft SA is a French private company founded in 2002.

    SEGAMI CORPORATION

    Segami Corporation is a Japanese private company with 1,501 employees.

    LABLOGIC SYSTEMS LTD.

    Lablogic Systems Ltd. is a United Kingdom-based private company founded in 1980.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Europe
    ~USD 2157.1 Million · 4.7% wtd CAGR ·
    Asia Pacific
    ~USD 1938.2 Million · 5.2% wtd CAGR ·
    Latin America
    ~USD 287.8 Million · 3.5% wtd CAGR ·
    Middle East & Africa
    ~USD 372.1 Million · 3.8% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 3311.5 Million
    CanadaUSD 244.1 Million

    Country market size visualization

    US
    USD 3311.5 Million
    Canada
    USD 244.1 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights into North America's nuclear medicine equipment market with country-level breakdowns for the US and Canada, enabling precise market targeting and localized business strategy development.
    • Competitive Intelligence : Understand North America's market dynamics, regulatory environment, and competitive landscape to identify growth opportunities and benchmark performance against regional leaders in diagnostic imaging.
    • Investment Decision Support : Access comprehensive forecasts through 2030 with 4.4% CAGR projections to support capital allocation decisions, facility expansion planning, and technology investment strategies in the North American healthcare sector.
    • Reimbursement & Regulatory Insights : Leverage region-specific analysis of North American reimbursement policies, FDA approvals, and healthcare regulations that directly impact nuclear medicine equipment adoption and market growth.
    • Strategic Partnership Opportunities : Identify high-growth segments and emerging applications within North America's nuclear medicine market to guide partnerships, acquisitions, and distribution channel development.

    Frequently asked questions

    What is the current size of North America's nuclear medicine equipment market?

    North America's nuclear medicine equipment market is estimated at $2,865.9 million in 2025.

    What is the projected market size for North America by 2030?

    North America's nuclear medicine equipment market is forecast to reach $3,555.6 million by 2030.

    What is the growth rate for North America's nuclear medicine equipment market?

    North America's nuclear medicine equipment market is expected to grow at a CAGR of 4.4% from 2025 to 2030.

    What factors are driving growth in North America's nuclear medicine equipment market?

    North America's market growth is driven by advanced healthcare infrastructure, aging demographics, increased chronic disease prevalence, strong reimbursement policies, and rising adoption of hybrid imaging systems.

    How does North America's nuclear medicine equipment market compare to global trends?

    North America's 4.4% CAGR is slightly below the global CAGR of 4.62%, reflecting the region's mature market status with steady, sustainable growth.

    RESEARCH METHODOLOGY

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the nuclear medicine equipment market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the nuclear medicine equipment market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Healthcare Information and Management Systems Society (HIMSS), Centers for Disease Control and Prevention (CDC), ClinicalTrials.gov, Expert Interviews, and MarketsandMarkets Analysis.

    Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the nuclear medicine equipment market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

    Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, and strategies adopted by key players.

    After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of nuclear medicine equipment offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

    In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

    Breakdown of Primary Interviews

    Nuclear Medicine Equipment Market

    Note 1: Other designations include sales, marketing, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue, as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product type, therapeutic area, dimension, end user, and region).

    Nuclear Medicine Equipment Market

    Data Triangulation

    After arriving at the overall market size, from the market size estimation process explained above, the nuclear medicine equipment market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the nuclear medicine equipment market.

    Market Definition

    Nuclear medicine equipment refers to specialized medical devices used to perform diagnostic and therapeutic procedures involving radioactive substances. These include imaging systems such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) scanners, as well as gamma cameras and hybrid imaging systems. The equipment enables the detection, imaging, and tracking of radiopharmaceuticals within the body, playing a crucial role in disease diagnosis, monitoring, and targeted radionuclide therapy.

    Stakeholders

    • Nuclear Medicine Equipment Vendors & Imaging Device Manufacturers
    • Healthcare Providers (Hospitals, Outpatient Settings, Diagnostics & Imaging Centers, Radiopharmacies, Other Healthcare Providers)
    • Clinical Research Organizations (CROs)
    • Research & Development (R&D) Companies
    • Business Research & Consulting Service Providers
    • Medical Research Laboratories
    • Academic Medical Centers/Universities/Hospitals/Research Institutes
    • Regulatory Bodies (FDA, EMA, IAEA)
    • AI & Algorithm Developers
    • Venture Capitalists
    • Advocacy Groups
    • Investors & Financial Institutions
    • Contract Manufacturing Organizations (CMOs)
    • Contract Research Organizations (CROs)

    Report Objectives

    • To define, describe, and forecast the nuclear medicine equipment market by product type, therapeutic area, dimension, end user, and region
    • To provide detailed information regarding the major drivers, restraints, opportunities, and challenges influencing market growth
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall nuclear medicine equipment market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the nuclear medicine equipment market in five main regions (and their respective countries): North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
    • To provide key industry insights, such as supply chain, regulatory, patent, and recession impact analysis
    • To profile the key players in the market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches & upgrades, collaborations, partnerships, acquisitions, investments, contracts, agreements, alliances, mergers, funding, and expansions of the leading players in the market
    • To benchmark players within the market using the company evaluation matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Get the Full Nuclear Medicine Equipment Market Report

    Full forecast, segment splits, and company analysis for all Nuclear Medicine Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status